Impact BioMedical, Inc (IBO) Financials

$0.54

$0.11 (24.14%)

As on 04-Sep-2026 16:28EDT

Market cap

$58 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

0.6

P/B Ratio

4.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.04	0.03	1.62	1.03	0.05	0.05
Cost of Revenue	0.71	0.42	1.12	1.12	1.11	1.11
Gross Profit	-0.39	-0.39	1.62	-1.12	0.05	0.05
Operating Expenses	4.71	3.88	28.75	4.03	3.45	3.45
Operating Profit (EBIT)	-5.10	-4.27	-28.75	-4.03	-3.40	-3.40
Other Income	--	--	--	--	--	--
Profit before Tax	-1.80	-14.45	-24.74	-4.41	-7.88	-7.88
Provision for Tax	-2.58	-2.58	0.03	--	-0.62	-0.62
Profit after Tax (Net Income)	0.79	-11.84	-24.71	-4.34	-7.05	-7.05
Minority Interest	0.01	0.03	0.06	0.07	0.20	0.20
Consolidated Profit	3.78	-11.84	-24.71	-4.34	-7.05	--

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	10.77	12.61	4.26	25.22	29.56	36.61
Minority Interest	0.01	--	--	--	--	--
Non-Current Liabilities	0.69	0.69	3.27	3.24	3.24	3.86
Current Liabilities	2.05	1.16	9.79	13.14	10.59	12.65
Total Liabilities	18.79	17.41	20.29	44.63	46.50	56.43

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	16.43	16.99	17.84	44.30	46.38	56.14
Current Assets	0.32	0.41	2.45	0.33	0.12	0.29
Total Assets	18.79	17.41	20.29	44.63	46.50	56.43
Total Debt*	--	--	8.88	12.07	9.99	12.52
Net Current Assets	-1.73	-0.75	-7.34	-12.80	-10.47	-12.36

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-1.89	-5.64	-2.85	-2.24	-2.24
Cash Flow from Investing Activities	--	0.00	0.00	-0.02	-0.35	-0.35
Cash from Financing Activities	--	-0.11	8.51	2.87	2.55	2.55
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	--	0.02	-0.38	-2.15	-0.38	-0.61
Cash EPS ($)	--	0.88	-0.34	-2.05	-0.28	-0.52
Adjusted Book Value ($)	--	0.10	0.40	0.37	2.19	2.57
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	-0.06	-0.49	-0.25	-0.19
Free Cash Flow per Share ($)	--	--	-0.06	-0.49	-0.25	-0.22

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	--	-91.96	-97.98	-11.29	-15.90
ROE (%)	--	6.86	-140.36	-167.62	-15.83	-21.31
ROA (%)	--	2.59	-62.81	-76.11	-9.52	-13.70
EBIT Margin (%)	--	-4,411.43	-42,678.13	-1,461.39	-384.76	-14,828.00
Net Margin (%)	--	2,254.29	-36,993.75	-1,525.34	-420.98	-14,102.00
Cash Profit Margin (%)	--	0.00	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	400.00	-0.98	0.57	19.60	--
EBIT Growth (%)	--	95.87	42.31	-497.33	46.55	--
Net Profit Growth (%)	--	102.09	52.09	-469.83	38.51	--
EPS Growth (%)	--	100.50	0.83	-4.70	0.39	--
Book Value Growth (%)	--	111.77	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	0.61	--	-0.68	--	--
Price / Book Value	--	4.59	--	3.92	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	4.72	--	-0.96	--	--
Close Price ($)	--	--	--	1.45	--	--
High Price ($)	--	--	--	3.25	--	--
Low Price ($)	--	--	--	1.16	--	--
Market Cap ($ Cr)	--	58.22	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	2.08	0.48	0.34
Short term debt to equity ratio	--	--	0.05	2.08	0.48	0.34
Current Ratio	--	0.16	0.35	0.25	0.03	0.01
Quick Ratio	--	0.13	0.30	0.25	--	--
Interest Coverage	--	0.02	-17.22	-201.63	-8.93	-16.05

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	562.86	634.38	11.36	32.14	32.00
Asset Turnover	--	0.00	0.00	0.05	0.02	0.00
Receivable days	--	--	2,208.62	58.06	61.53	777.98
Inventory Days	--	--	27.02	-0.09	--	--
Payable days	--	--	284.71	187.03	223.55	107.31
Cash Conversion Cycle	--	--	1,950.94	-129.06	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.